Approval · Notice of Compliance 3576 · 2003
SIMVASTATIN: Notice of Compliance 3576
Issued April 30, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3576
- Date
- April 30, 2003
- Company
- Prempharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- ZOCOR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIMVASTATIN | 02247531 | Cancelled Post Market |
| SIMVASTATIN | 02247532 | Cancelled Post Market |
| SIMVASTATIN | 02247533 | Cancelled Post Market |
| SIMVASTATIN | 02247534 | Cancelled Post Market |
| SIMVASTATIN | 02247535 | Cancelled Post Market |
Medicinal ingredients
- SIMVASTATIN 5 MG per TAB
- SIMVASTATIN 10 MG per TAB
- SIMVASTATIN 20 MG per TAB
- SIMVASTATIN 40 MG per TAB
- SIMVASTATIN 80 MG per TAB